Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Liposome (VS-1024-FY30) (CAT#: VS-1024-FY30)

The anti-mTOR antibody-conjugated liposomes show potential application value in the treatment of human colon cancer. Research indicates that these liposomes can enhance the therapeutic effects on colon cancer by activating the Akt/mTOR and P53 pathways.
Anti-mTOR antibody-conjugated liposomes can potentially regulate the mTOR signaling pathway in ischemic myocardium, promoting cellular metabolism and autophagy processes, thereby improving cardiac function.
Anti-mTOR antibody conjugated liposomes hold significant promise in the treatment of adrenocortical carcinoma by enabling targeted delivery of therapeutic agents directly to cancer cells expressing the mTOR pathway. This specificity can enhance the effectiveness of the treatment while minimizing off-target effects, potentially improving patient outcomes. Moreover, the use of liposomes can facilitate the sustained release of drugs, increasing the duration of therapeutic action and potentially leading to better tumor control. Furthermore, this approach can also serve as a valuable research tool to study mTOR-related signaling pathways in adrenocortical carcinoma and identify new therapeutic targets.
Anti-mTOR antibody conjugated liposomes have significant potential in the treatment of metastatic fibrosarcoma by specifically targeting the mTOR pathway, which is often dysregulated in cancer cells. This targeted delivery mechanism enhances the therapeutic efficacy of anti-cancer agents while minimizing systemic toxicity. Additionally, the use of liposomes can improve drug solubility and stability, facilitating better penetration into tumor tissues. Overall, this approach may lead to improved outcomes in patients with metastatic fibrosarcoma by providing a more precise and effective treatment option.

Sub Cat Product Name Liposome Name Datasheet  
VS-1124-FY494 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled PEGylated Liposome (VS-1124-FY494) PEGylated liposome
VS-1124-FY495 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Triptolide-loaded Liposome (VS-1124-FY495) Triptolide-loaded liposome
VS-1124-FY496 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Gd-SLs Liposome (VS-1124-FY496) Gd-SLs liposome
VS-1124-FY497 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Phospholipid Liposome (VS-1124-FY497) Phospholipid liposome
VS-1124-FY498 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Cationic Liposome (VS-1124-FY498) Cationic liposome
VS-1124-FY499 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Adriamycin-encapsulated Liposome (VS-1124-FY499) Adriamycin-encapsulated liposome
VS-1124-FY500 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Magnetofluorescent Liposome (VS-1124-FY500) Magnetofluorescent liposome
VS-1124-FY501 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled pH-sensitive Liposome (VS-1124-FY501) pH-sensitive liposome
VS-1124-FY502 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Phototoxic Liposome (VS-1124-FY502) Phototoxic liposome
VS-1124-FY503 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Targeted Liposome (VS-1124-FY503) Targeted Liposome
VS-1124-FY504 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Apt1-Liposome (VS-1124-FY504) Apt1-liposome
VS-1124-FY505 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Thermosensitive Liposome (VS-1124-FY505) Thermosensitive liposome
VS-1124-FY506 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Clodronate Liposome (VS-1124-FY506) Clodronate liposome
VS-1124-FY507 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Galcer Liposome (VS-1124-FY507) Galcer liposome
VS-1124-FY508 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled HBsAg-loaded Liposome (VS-1124-FY508) HBsAg-loaded liposome
VS-1124-FY509 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled Phospholipid Liposome and Cationic Liposome (VS-1124-FY509) Phospholipid liposome and Cationic liposome
VS-1124-FY510 Anti-mTOR (clone W24V29) Recombinant Antibody Coupled ISMN Liposome (VS-1124-FY510) ISMN liposome
More Infomation
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Potential Clinical Applications
  • Human colon carcinoma, Ischemic myocardium in vivo, Adrenocortical carcinoma, Metastatic fbrosarcoma

Product Composition

  • Clone
  • W24V29
  • Antibody Type
  • IgG
  • Antibody Host
  • Mouse
  • Antibody Reactivity
  • Human
  • Antibody Description
  • This product is a recombinant antibody derived from mouse sources, specifically designed to target the mechanistic target of rapamycin (mTOR). mTOR is a critical protein kinase that plays a pivotal role in regulating cellular processes such as growth, proliferation, metabolism, and autophagy.

Product Property

  • Storage
  • See in the COA
  • Storage Shelf Time
  • See in the COA

Target Information

  • Target
  • mTOR
  • Introduction
  • The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. The ANGPTL7 gene is located in an intron of this gene.
  • Alternative Names
  • Mechanistic Target Of Rapamycin Kinase; Rapamycin And FKBP12 Target 1; Mammalian Target Of Rapamycin; FK506-Binding Protein 12-Rapamycin Complex-Associated Protein 1; Mechanistic Target Of Rapamycin (Serine/Threonine Kinase); FK506 Binding Protein 12-Rapamycin Associated Protein 2; FKBP12-Rapamycin Complex-Associated Protein 1; Rapamycin Associated Protein FRAP2; FKBP-Rapamycin Associated Protein; Mechanistic Target Of Rapamycin; Rapamycin Target Protein 1; FRAP1; FRAP2
  • Full Name
  • Mechanistic Target Of Rapamycin Kinase
  • Sequence Similarities
  • Belongs to the PI3/PI4-kinase family.
  • Cellular Localization
  • Cytoplasm, Cytoplasmic vesicle, Endoplasmic reticulum, Golgi apparatus, Lysosome, Membrane, Microsome, Mitochondrion, Mitochondrion outer membrane, Nucleus
  • Post Translation Modifications
  • Autophosphorylates when part of mTORC1 or mTORC2. Phosphorylation at Ser-1261, Ser-2159 and Thr-2164 promotes autophosphorylation. Phosphorylation in the kinase domain modulates the interactions of MTOR with RPTOR and PRAS40 and leads to increased intrinsic mTORC1 kinase activity. Phosphorylation at Thr-2173 in the ATP-binding region by AKT1 strongly reduces kinase activity.
  • Function
  • Serine/threonine protein kinase which is a central regulator of cellular metabolism, growth and survival in response to hormones, growth factors, nutrients, energy and stress signals. MTOR directly or indirectly regulates the phosphorylation of at least 800 proteins. Functions as part of 2 structurally and functionally distinct signaling complexes mTORC1 and mTORC2. Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. This includes phosphorylation of EIF4EBP1 and release of its inhibition toward the elongation initiation factor 4E (eiF4E) (By similarity). Moreover, phosphorylates and activates RPS6KB1 and RPS6KB2 that promote protein synthesis by modulating the activity of their downstream targets including ribosomal protein S6, eukaryotic translation initiation factor EIF4B, and the inhibitor of translation initiation PDCD4. This also includes mTORC1 signaling cascade controlling the MiT/TFE factors TFEB and TFE3: in the presence of nutrients, mediates phosphorylation of TFEB and TFE3, promoting their cytosolic retention and inactivation. Upon starvation or lysosomal stress, inhibition of mTORC1 induces dephosphorylation and nuclear translocation of TFEB and TFE3, promoting their transcription factor activity. Stimulates the pyrimidine biosynthesis pathway, both by acute regulation through RPS6KB1-mediated phosphorylation of the biosynthetic enzyme CAD, and delayed regulation, through transcriptional enhancement of the pentose phosphate pathway which produces 5-phosphoribosyl-1-pyrophosphate (PRPP), an allosteric activator of CAD at a later step in synthesis, this function is dependent on the mTORC1 complex. Regulates ribosome synthesis by activating RNA polymerase III-dependent transcription through phosphorylation and inhibition of MAF1 an RNA polymerase III-repressor.

Related Resources

  • Related Signaling Pathways
  • Related Diseases

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "MTOR"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products Rabbit Monoclonal Antibody Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-1024-FY30. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare